Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00556907 · ClinicalTrials.gov registry record · NA
Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT00556907 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 36 participants.
The verdict
NCT00556907, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
We hypothesize that the combination of mammography and CE-MRI will improve the surgeon and radiologist's ability to define extent of disease prior to surgical resection, improve the odds of obtaining clear surgical margins, and increase the efficacy of IORT delivered immediately after initial surgical resection. In this investigation, we will determine whether or not patients deemed eligible for 'immediate" IORT based on mammography and CE-MRI can be successfully treated without the need for re-excision or additional radiotherapy due to inadequate surgical margins.
Interventions
- RADIATION Intraoperative radiotherapy
- DEVICE Intraoperative radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2007-10 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00556907
The ClinicalTrials.gov registry entry for NCT00556907 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intraoperative radiotherapy is the first listed.
NCT00556907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00556907 about?
NCT00556907 is a clinical study titled "Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast". We hypothesize that the combination of mammography and CE-MRI will improve the surgeon and radiologist's ability to define extent of disease prior to surgical resection, improve the odds of obtaining clear surgical margins, and increase the efficacy of IORT delivered immediately after initial surgic...
What is the current status of trial NCT00556907?
This trial is currently terminated. It is a NA study. The enrollment target is 36 participants. The study started on 2007-10. Estimated completion is 2016-11.
What interventions are being tested in trial NCT00556907?
The interventions under investigation include: Intraoperative radiotherapy (RADIATION), Intraoperative radiotherapy (DEVICE).
Who is sponsoring clinical trial NCT00556907?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.